36 filings
8-K
IMPL
Impel Pharmaceuticals Inc
12 Mar 24
Amendments to Articles of Incorporation or Bylaws
8:43am
8-K
IMPL
Impel Pharmaceuticals Inc
14 Feb 24
Entry into a Material Definitive Agreement
5:15pm
8-K
IMPL
Impel Pharmaceuticals Inc
2 Jan 24
Other Events
4:23pm
8-K
IMPL
Impel Pharmaceuticals Inc
20 Dec 23
Impel Pharmaceuticals Announces Filing Voluntary Chapter 11 Cases and Signing of “Stalking Horse” Agreement to Facilitate Sale
6:08am
8-K
IMPL
Impel Pharmaceuticals Inc
18 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:31am
8-K
6rl1e5kiu1
4 Dec 23
Departure of Directors or Certain Officers
6:05am
8-K
h47zqd gcy
14 Nov 23
Departure of Directors or Certain Officers
4:01pm
8-K
uorvmag1tuy1bn 7i7xc
2 Nov 23
Departure of Directors or Certain Officers
5:20pm
8-K
669ah1i33 e4
16 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:33pm
8-K
dllty
4 Oct 23
Entry into a Material Definitive Agreement
5:21pm
8-K
veqba1h
18 Sep 23
Regulation FD Disclosure
9:53pm
8-K
orotdqpzz0d1c1go9b
7 Sep 23
Entry into a Material Definitive Agreement
4:19pm
8-K
4yz7sy
21 Aug 23
Entry into a Material Definitive Agreement
8:33am
8-K
zvt8o
16 Jun 23
Submission of Matters to a Vote of Security Holders
9:18am
8-K
ej3r 3d1qe47xl0s
12 May 23
Impel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update
8:03am
8-K
xguyqh5uxtbb0p
10 May 23
Departure of Directors or Certain Officers
8:10am
8-K
5li1mz
17 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:33pm
8-K
n16xluw6d9skam5x
12 Apr 23
Departure of Directors or Certain Officers
4:06pm
8-K
ag17fu0rmx
24 Mar 23
Impel Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
8:21am
8-K
n0zel32q4j7k903
3 Mar 23
Departure of Directors or Certain Officers
4:06pm